Yuko Shirota
Overview
Explore the profile of Yuko Shirota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takeyama S, Hanaoka H, Hashimoto A, Ishii Y, Shimizu Y, Takeuchi T, et al.
BMC Rheumatol
. 2025 Feb;
9(1):25.
PMID: 40012072
Background: Pulmonary hypertension (PH) is the leading cause of death among patients with systemic sclerosis (SSc). Recently, early therapeutic intervention to improve the prognosis was suggested, and the definition of...
2.
Shirai T, Ishii T, Okazaki S, Shirota Y, Ishii Y, Sato H, et al.
Front Immunol
. 2025 Jan;
15():1473100.
PMID: 39840060
Objectives: The feasibility of corticosteroid withdrawal (CW) for Takayasu arteritis (TAK) remains uncertain. Two autoantibodies (Abs) are identified against endothelial protein C receptor (EPCR) and scavenger receptor class B type...
3.
Shirota Y, Ohmori S, Engel J, Moriguchi T
PLoS One
. 2024 Dec;
19(12):e0315446.
PMID: 39739870
The vascular endothelium is vital for cardio-pulmonary homeostasis and, thus, plays a crucial role in preventing life-threatening lung diseases. The transcription factor GATA2 is essential for hematopoiesis and maintaining vascular...
4.
Ishii T, Kawaguchi Y, Ishikawa O, Takemori H, Takasawa N, Kobayashi H, et al.
Mod Rheumatol
. 2024 Nov;
PMID: 39562303
Objectives: Systemic sclerosis is characterised by ischaemic skin ulcers on the fingertips, and low-energy shock wave therapy is suggested as a novel treatment for ischaemic lesions with angiogenic effects. We...
5.
Sato T, Fukui S, Nakano T, Hasegawa K, Kikuta H, Kameyama T, et al.
Pulm Circ
. 2024 Apr;
14(2):e12377.
PMID: 38681871
Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic disease that can rapidly deteriorate into circulatory collapse when complicated by comorbidities. We herein describe a case involving a 43-year-old woman with...
6.
Sato H, Kanno A, Sato M, Endo A, Ito H, Ohara T, et al.
Front Immunol
. 2023 Oct;
14:1266187.
PMID: 37901232
Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a rare condition with diverse clinical and pathological characteristics related to multi-organ damage. We report a case of TAFRO syndrome...
7.
Shimada T, Itagaki H, Shirota Y, Endo T
Medicina (Kaunas)
. 2023 May;
59(5).
PMID: 37241048
Aortitis is a rare complication of the coronavirus disease 2019 (COVID-19) and is often treated empirically with steroids. We present a case of spontaneous resolution of aortitis without treatment. A...
8.
Sato T, Fukui S, Shirota Y, Hasegawa K, Kikuta H, Kameyama T, et al.
Circ J
. 2023 Feb;
87(5):670.
PMID: 36792183
No abstract available.
9.
Furukawa H, Nomura J, Kobayashi M, Abe S, Takeda T, Oka Y, et al.
Tohoku J Exp Med
. 2022 Nov;
259(2):113-119.
PMID: 36450481
Lenalidomide (LEN), one of the key drugs in the treatment of myelodysplastic syndromes (MDS) with 5q deletion, as well as multiple myeloma (MM), has various immunomodulatory effects and has been...
10.
Fukui S, Shirota Y, Nakano T, Sato T, Hasegawa K, Kikuta H, et al.
Life (Basel)
. 2022 Nov;
12(11).
PMID: 36362952
Balloon pulmonary angioplasty (BPA) has been reported to be effective and safe to an acceptable level in patients with distal-type, inoperable chronic thromboembolic pulmonary hypertension (CTEPH), resulting in improved long-term...